The 4th International Workshop on Acute Leukemias (iwAL) 2022 took
place in Nice, France, and brought together leading experts in the field as
they discussed several topics. In this podcast series, you will hear the
latest updates in acute myeloid leukemia (AML) and acute lymphoblastic
leukemia (ALL) and gain an insight into the sessions that took place at this
year’s meeting.
The first session from iwAL focused on the standard of care in AML in
2022. In this podcast, Mark Levis, MD, PhD, Johns Hopkins Sidney Kimmel
Comprehensive Cancer Center, Baltimore, MD, Eunice Wang, MD, Roswell
Park Comprehensive Cancer Center, Buffalo, NY, Jessica Altman, MD,
Robert H. Lurie Comprehensive Cancer Center, Northwestern University,
Chicago, IL, and Charles Craddock, CBE, FRCP, FRCPath, DPhil, University
of Birmingham, Birmingham, UK, discuss and debate the current standard
of care in AML in 2022, commenting on the role of transplantation and
novel agents, as well as treatment approaches for relapsed FLT3-mutated
disease.
Create your
podcast in
minutes
It is Free